Petros pharmaceuticals featured in “new era of healthcare, ai, data and consumer empowerment”

Company positions itself for new innovation utilizing ai and quantum computing to help expand patient access to drugs via otc access new york, ny / accesswire / december 19, 2024 / petros pharmaceuticals, inc. (nasdaq:ptpi) ("petros" or the "company"), a company focused on expanding consumer access to medication through over the counter ("otc") drug development programs, today announced that in a recent podcast, the intelligent leadership podcast, titled, "the new era of healthcare, ai, data and consumer empowerment," petros president fady boctor discussed the company's concerted efforts to develop its proprietary platform as a prospective technology driven rx-to-otc switch solution across a multitude of conditions and existing rx only therapies. during the podcast, boctor discussed petros' technology tool development around a drug facts label to self-select, as well as the utilization of ai to ensure safe engagement and access to a drug that has made the rx-to-otc switch.
PTPI Ratings Summary
PTPI Quant Ranking